Description
Targit 40 – strips of 10 Tablets
(Telmisartan 40mg, Strip of 15 Uncoated Tablets)
1. Active Ingredient
-
Telmisartan IP – 40mg (Angiotensin II Receptor Blocker/ARB)
2. Key Characteristics
-
Class: Non-peptide ARB (AT1 subtype selective)
-
Bioavailability: 42% (high fat meal increases absorption by 6-20%)
-
Half-life: 24 hours (permits once-daily dosing)
-
Protein Binding: >99.5% (mainly to albumin)
3. Approved Indications
✔ Hypertension (First-line treatment)
✔ Cardiovascular Risk Reduction in patients unable to take ACE inhibitors
✔ Diabetic Nephropathy (off-label use in India)
4. Dosage & Administration
-
Standard Dose: 40mg once daily (may increase to 80mg)
-
Best Taken: With/without food (consistent timing recommended)
-
Crushing: Not recommended (uncoated but not scored)
5. Mechanism of Action
-
Selectively blocks AT1 receptors →
-
Vasodilation (reduced peripheral resistance)
-
Decreased aldosterone secretion
-
No effect on bradykinin metabolism (unlike ACE inhibitors)
-
6. Advantages Over Other ARBs
✓ Longest half-life (24 hrs vs Losartan’s 6-9 hrs)
✓ PPAR-γ modulation (additional metabolic benefits)
✓ Renal excretion <1% (safer in renal impairment)
7. Contraindications
✖ Bilateral renal artery stenosis
✖ Severe hepatic impairment (Child-Pugh C)
✖ Pregnancy (FDA Category D in 2nd/3rd trimesters)
8. Drug Interactions
⚠ NSAIDs: Reduced antihypertensive effect
⚠ Digoxin: May increase serum levels (monitor)
⚠ Ramipril: Increased risk of hyperkalemia
9. Adverse Effects
-
Common (≥1%):
-
Dizziness (3.1%)
-
Back pain (2.9%)
-
Sinusitis (2.3%)
-
-
Serious (Rare):
-
Angioedema (<0.1%)
-
Hyperkalemia (risk in CKD patients)
-
10. Special Populations
-
Elderly: No dose adjustment needed
-
Renal Impairment: Safe down to CrCl 15ml/min
-
Hepatic Impairment: Max 40mg/day in Child-Pugh B
11. Storage Conditions
-
Temperature: Below 30°C
-
Protection: Keep in original blister
-
Shelf Life: Typically 36 months
12. Market Position
-
Price Range: ₹120-150 per strip (15 tablets)
-
Comparable Brands:
-
Telma (Glenmark)
-
Telsartan (Sun Pharma)
-
Telvas (Aristo Pharma)
-
13. Clinical Pearls
-
Preferred in Metabolic Syndrome:
Shows PPAR-γ activity → improves insulin sensitivity -
Morning vs Bedtime Dosing:
Evening administration may better control nocturnal BP
14. Manufacturer Details
-
Marketing Authorization Holder: Pfizer Limited
-
Manufacturing Site: Likely Goa plant (FDA-approved facility)
15. Available Strengths
-
Other variants: Targit 20 (20mg), Targit 80 (80mg)
Therapeutic Alternatives
Brand | Manufacturer | Cost/Strip | Key Difference |
---|---|---|---|
Telma 40 | Glenmark | ₹110-130 | Most prescribed generic |
Telsartan 40 | Sun Pharma | ₹95-110 | Sugar-free formulation |
Telvas 40 | Aristo | ₹85-100 | Budget option |
Reviews
There are no reviews yet.